L’anticorps anti-PALLD Polyclonal Lapin est utilisé pour la détection de PALLD dans des échantillons de Humain et Souris. Il a été validé pour IHC, ELISA et IF.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300,ELISA 1:20000,IF 1:50-200
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
PALLD
(Palladin, Cytoskeletal Associated Protein (PALLD))
Autre désignation
Palladin
Sujet
PALLD, KIAA0992, CGI-151, Palladin, SIH002, Sarcoma antigen NY-SAR-77PALLD encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The palladin, cytoskeletal associated protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.